Joseph Todisco - May 10, 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Executive Officer, Director
Signature
/s/ Joseph Todisco
Stock symbol
CRMD
Transactions as of
May 10, 2022
Transactions value $
$0
Form type
4
Date filed
5/12/2022, 04:30 PM
Previous filing
May 10, 2022
Next filing
May 17, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Award $0 +207K $0.00 207K May 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +500K $0.00 500K May 10, 2022 Common Stock 500K $3.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Restricted Stock Units were granted on 5/10/2022. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest as follows: 50% on the first anniversary of the grant date, 30% on the second anniversary of the grant date, and the remaining 20% on the third anniversary of the grant date, subject to continued service through the applicable vesting date.
F2 These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.